In the Star Trek franchise, the first human being to ever meet a Klingon on the timeline isn't an astronaut or an adventurer, ...
The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a variety of age-related disease.